Options
Excessive Release Of Inorganic Polyphosphate By Als/Ftd Astrocytes Causes Non-Cell-Autonomous Toxicity To Motoneurons
Date Issued
2022-03-10
Author(s)
Cristián Arredondo
Carolina Cefaliello
Agnieszka Dyrda
Nur Jury
Pablo Martínez
Iván Darío Parrado Díaz
Armando Amaro
Hélène Tran
Danna Morales
Marı́a Pertusa
Lorelei Stoica
Elsa Fritz
Daniela Corvalán
Sebastián Abarzúa
Maxs Méndez-Ruette
Paola Fernández
Fabiola Rojas
Meenakshi Sundaram Kumar
Rodrigo Aguilar
Sandra Almeida
Alexandra Weiss
Fernando J. Bustos
Fernando D. González‐Nilo
Carolina Otero
María Florencia Tevy
Daryl A. Bosco
Thilo Kähne
Fen‐Biao Gao
James Berry
Katharine Nicholson
Miguel Sena‐Esteves
Rodolfo Madrid
Diego Varela
Martı́n Montecino
Robert H. Brown
Brigitte van Zundert
WoS ID
WOS:000806724800010
Abstract
Non-cell-autonomous mechanisms contribute to neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), in which astrocytes release unidentified factors that are toxic to motoneurons (MNs). We report here that mouse and patient iPSC-derived astrocytes with diverse ALS/FTD-linked mutations (SOD1, TARDBP, and C9ORF72) display elevated levels of intracellular inorganic polyphosphate (polyP), a ubiquitous, negatively charged biopolymer. PolyP levels are also increased in astrocyte-conditioned media (ACM) from ALS/FTD astrocytes. ACM-mediated MN death is prevented by degrading or neutralizing polyP in ALS/FTD astrocytes or ACM. Studies further reveal that postmortem familial and sporadic ALS spinal cord sections display enriched polyP staining signals and that ALS cerebrospinal fluid (CSF) exhibits increased polyP concentrations. Our in vitro results establish excessive astrocyte-derived polyP as a critical factor in non-cell-autonomous MN degeneration and a potential therapeutic target for ALS/FTD. The CSF data indicate that polyP might serve as a new biomarker for ALS/FTD.
Subjects
OCDE Subjects
Quartile (Date Issued)
Q1
License
acceso abierto